Pfizer
PFE
PFE
2,727 hedge funds and large institutions have $145B invested in Pfizer in 2021 Q2 according to their latest regulatory filings, with 187 funds opening new positions, 1,281 increasing their positions, 998 reducing their positions, and 97 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 2,670 → 2,727 (+57)
0.55% more ownership
Funds ownership: 65.86% → 66.41% (+0.55%)
10% less call options, than puts
Call options by funds: $2.23B | Put options by funds: $2.47B
Holders
2,727
Holding in Top 10
70
Calls
$2.23B
Puts
$2.47B
Top Buyers
| 1 | +$393M | |
| 2 | +$356M | |
| 3 | +$206M | |
| 4 |
D.E. Shaw & Co
New York
|
+$178M |
| 5 |
N
Natixis
Paris,
France
|
+$172M |
Top Sellers
| 1 | -$313M | |
| 2 | -$290M | |
| 3 | -$181M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$153M |
| 5 |
JP Morgan Chase
New York
|
-$143M |